Journals / Van Tıp Dergisi / 2019 / Cilt: 26 - Sayı: 3

A Review of Effects of Low-Level Laser Therapy On Bisphosphonate-Related Jaw Necrosis

Bifosfonatlarla İlişkili Çene Kemiği Nekrozunda Düşük Doz Lazer Terapisinin Etkisi Üzerine Durum Değerlendirmesi

Pages
392–401
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, in this literature review, the outcomes of applications of low level laser therapy performed for the treatment of bisphosphonate-related jaw necrosis between 2006 and 2017 are presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Seeking different therapeutic options for clinical success in bisphosphonate-related jaw osteonecrosis, the treatment of which may be considered difficult, is an ongoing issue for a long time.
📊
Key Findings & Data:The use of low level laser therapy in jaw osteonecrosis has been among the alternative treatment options for the last 11 years.
💡
Conclusion & Impact:Thus, in this literature review, the outcomes of applications of low level laser therapy performed for the treatment of bisphosphonate-related jaw necrosis between 2006 and 2017 are presented.
🔬Design:Review & Systematic Survey
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Seeking different therapeutic options for clinical success in bisphosphonate-related jaw osteonecrosis, the treatment of which may be considered difficult, is an ongoing issue for a long time. The use of low level laser therapy in jaw osteonecrosis has been among the alternative treatment options for the last 11 years. However, it remains unclear if low level laser therapy is indeed a single treatment or a supportive therapy. Thus, in this literature review, the outcomes of applications of low level laser therapy performed for the treatment of bisphosphonate-related jaw necrosis between 2006 and 2017 are presented.

Özet

Bifosfonata bağlı gelişen çene osteonekrozları, tedavisi oldukça zor olabilen, klinik başarı için farklı arayışların uzun zamandır devam ettiği bir konudur. Düşük doz lazer terapisinin çene osteonekrozlarında kullanımı son 11 yıldır alternatif tedavi seçenekleri arasında yer almaktadır. Fakat gerçekten tek başına ya da destekleyici bir tedavi yöntemi mi olduğu netleşmemiştir. Bu nedenle bu literatür derlemesinde bifosfonata bağlı gelişen çene nekrozlarının tedavisinde 2006- 2017 yılları arasında yapılan düşük seviyeli lazer terapi uygulamalarının sonuçları sunulmuştur.

🔖

Cite This Article

EROĞLU, C. N. (2019). A Review of Effects of Low-Level Laser Therapy On Bisphosphonate-Related Jaw Necrosis. Van Tıp Dergisi, Cilt: 26 - Sayı: 3, 392–401. https://ajindex.com/articles/334801

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Marx RE. Pamidronate (Aredia) and Zoledronate (Zometa) Induced Avascular Necrosis of The Jaws: A Growing Epidemic. J Oral Maxillofac Surg 2003;61:1115-1118
  2. Ruggiero S, Dodson T, Fantasia J, Gooodday R, Aghaloo T, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 Update. JOMS, 72,10:1938-1956 3. Favia G, Piattelli A, Sportelli P, Capodiferro S, Iezzi G. Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report. Clin Implant Dent Relat Res. 2011 Mar;13(1):58-63
  3. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res. 2009 Sep;20 Suppl 4:87-95
  4. Çömez K, Şen V, Aslan G. Bifosfonat Kullanımına Bağlı Mandibulada Osteonekroz: Olgu Sunumu. Üroonkoloji Bülteni.2009,13:255- 257
  5. Marx RE. Oral & Intravenous BisphosphonatesInduced Osteonecrosis of the Jaws:History, Etiology, Prevention and Treatment. Ouintessence Publishing (IL), 1st ed. 2006
  6. Reilly MM. Osteonecrosis of the jaw in a patient receiving bisphosphonate therapy. Oncol Nurs Forum, 2007,34;2:301-305
  7. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005 Dec 1;23(34):8580-7
  8. Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol. 2007 Sep;78(9):1664-9
  9. Adornato MC, Morcos I, Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc. 2007 Jul;138(7):971-7
  10. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006 May 16;144(10):753-61. Review
  11. Zafersoy Akarslan Z, Altundağ Kahraman S. Kemik metastazı yapmış prostat kanseri tedavisinde kullanılan bifosfonata bağlı gelişen osteonekroz: Vaka Raporu ve Literatür Derlemesi. Atatürk Üniv. Diş. Hek. Fak. Derg. 2008 18 (3):105-110
  12. Akgül C. Bifosfonatlar ve çene kemiği üzerindeki etkileri, Ege Ünivers